This inventor holds 2 USPTO granted patents. Top assignee: Chong Kun Dang Corporation. Active years: 1997-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-1998
Title: Hyo Sung Kwak: Innovator in Carbapenem Derivatives
Introduction
Hyo Sung Kwak is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of carbapenem derivatives. With a total of 2 patents, his work is recognized for its potential impact on antibiotic development.
Latest Patents
Hyo Sung Kwak's latest patents include innovative compounds such as 2-(2-Substituted pyrrolidin-4-yl) thio-carbapenem derivatives. This invention relates to a mercaptopyrrolidinyl derivative suitable for the preparation of carbapenem compounds. These compounds are crucial in the fight against antibiotic-resistant bacteria.
Career Highlights
Kwak is currently associated with Chong Kun Dang Corporation, a prominent pharmaceutical company in South Korea. His work at the company focuses on advancing research in antibiotic therapies and improving existing medicinal formulations.
Collaborations
Some of his notable coworkers include Chong Ryul Lee and Sang Choon Lee, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Hyo Sung Kwak's contributions to the field of medicinal chemistry, particularly through his patents, highlight his role as an innovator in the development of essential pharmaceutical compounds. His work continues to influence the landscape of antibiotic research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile